10-104122194-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001002759.2(SFR1):c.11G>A(p.Gly4Glu) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000179 in 1,394,044 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 18/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_001002759.2 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SFR1 | NM_001002759.2 | c.11G>A | p.Gly4Glu | missense_variant, splice_region_variant | 1/4 | ENST00000369727.4 | NP_001002759.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SFR1 | ENST00000369727.4 | c.11G>A | p.Gly4Glu | missense_variant, splice_region_variant | 1/4 | 2 | NM_001002759.2 | ENSP00000358742 | A1 | |
SFR1 | ENST00000369729.7 | c.-27+40G>A | intron_variant | 1 | ENSP00000358744 | P4 | ||||
SFR1 | ENST00000463224.5 | n.97+40G>A | intron_variant, non_coding_transcript_variant | 3 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome AF: 0.0000179 AC: 25AN: 1394044Hom.: 0 Cov.: 31 AF XY: 0.0000160 AC XY: 11AN XY: 687722
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 21, 2022 | The c.11G>A (p.G4E) alteration is located in exon 1 (coding exon 1) of the SFR1 gene. This alteration results from a G to A substitution at nucleotide position 11, causing the glycine (G) at amino acid position 4 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at